U.S. Markets closed

RegeneRx Biopharmaceuticals, Inc. (RGRX)


Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.28450.00 (0.00%)
At close: 2:17PM EDT
People also watch
LCARPRTXAOLSSNGXPHLI
Interactive chart
Previous Close0.2845
Open0.2845
Bid0.0000 x
Ask0.0000 x
Day's Range0.2800 - 0.2845
52 Week Range0.2500 - 0.5800
Volume11,115
Avg. Volume22,117
Market Cap30.41M
Beta1.88
PE Ratio (TTM)142.25
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • RegeneRx Biopharmaceuticals, Inc. :RGRX-US: Earnings Analysis: Q1, 2017 By the Numbers : May 26, 2017
    Capital Cube16 hours ago

    RegeneRx Biopharmaceuticals, Inc. :RGRX-US: Earnings Analysis: Q1, 2017 By the Numbers : May 26, 2017

    Categories: Yahoo FinanceGet free summary analysis RegeneRx Biopharmaceuticals, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of RegeneRx Biopharmaceuticals, Inc. – MediWound Ltd., XOMA Corporation, Novartis AG Sponsored ADR, Sevion Therapeutics, Inc., Akorn, Inc., Johnson & Johnson, Rigel Pharmaceuticals, Inc., Sucampo Pharmaceuticals, Inc. Class A, ... Read more (Read more...)

  • RegeneRx Biopharmaceuticals, Inc. :RGRX-US: Earnings Analysis: Q4, 2016 By the Numbers : March 31, 2017
    Capital Cube2 months ago

    RegeneRx Biopharmaceuticals, Inc. :RGRX-US: Earnings Analysis: Q4, 2016 By the Numbers : March 31, 2017

    Categories: Yahoo Finance Get free summary analysis RegeneRx Biopharmaceuticals, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of RegeneRx Biopharmaceuticals, Inc. – MediWound Ltd., XOMA Corporation, Sevion Therapeutics, Inc., Akorn, Inc., Rigel Pharmaceuticals, Inc., Sucampo Pharmaceuticals, Inc. Class A, Mateon Therapeutics, Inc. and Capstone Therapeutics Corp. ... Read more (Read more...)

  • RegeneRx Biopharmaceuticals, Inc. :RGRX-US: Earnings Analysis: Q3, 2016 By the Numbers : November 23, 2016
    Capital Cube6 months ago

    RegeneRx Biopharmaceuticals, Inc. :RGRX-US: Earnings Analysis: Q3, 2016 By the Numbers : November 23, 2016

    Categories: Yahoo Finance Get free summary analysis RegeneRx Biopharmaceuticals, Inc. reports financial results for the quarter ended September 30, 2016. We analyze the earnings along side the following peers of RegeneRx Biopharmaceuticals, Inc. – MediWound Ltd., XOMA Corporation, Novartis AG Sponsored ADR, Sevion Therapeutics, Inc., Akorn, Inc., Johnson & Johnson, Mateon Therapeutics, Inc., Rigel Pharmaceuticals, Inc., Sucampo Pharmaceuticals, ... Read more (Read more...)